Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07726082

Micro-choice-based Intervention for Multicausal Fatigue

Conditions: Multicausal Fatigue, Fatigue, Post COVID Condition, Long COVID Syndrome, Postviral Fatigue

Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 24
Sponsor: University Hospital, Basel, Switzerland

Location: University Hospital Basel Basel

Summary

This proof-of-concept study aims to evaluate the feasibility, acceptability, and potential benefits of a novel multimodal approach: the micro-choice-based intervention.

Eligibility Criteria

Inclusion Criteria: * Experiencing persistent fatigue with a significant impact on daily functioning (Chalder Fatigue- Scale bimodal ≥ 4) Exclusion Criteria: * Have insufficient proficiency in German to complete study-related questionnaires * Lack the cognitive capacity to understand study procedures (e.g. due to dementia) * Present with severe medical conditions that may interfere with participation (e.g., advanced organ failure, uncontrolled inflammatory or autoimmune diseases, or severe psychiatric disorders) * Have active cancer or are currently undergoing cancer treatment * Are deemed incompatible with group participation during the preparation phase, based on a team assessment. Reasons for exclusion based on group incompatibility include: (-Need for a level of individual therapeutic support that exceeds what can be provided in a group setting; -Refusal to engage in group-based therapy; -Personality traits that are considered incompatible with group dynamics; -Failure to attend the mandatory preparatory webinar (no-show is considered a no-go); -Other significant reasons as determined by the therapeutic team)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07726082). StuddyBuddy aggregates publicly available trial information.